After the transplantation of genetically engineered MSCs as the delivery vehicles of BDNF, NGF or VEGF, significant behavioural recovery and reduction of striatal degeneration was observed in mice with experimental HD [155–157]. This evidence concerns the gene BDNF and Huntington disease.